Accueil › 🇺🇸 États-Unis › Santé Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity 📅 12/05/2026 06:00 📰 globenewswire 👁️ 0 lectures 🌍 États-Unis 📂 Santé Higher-dose Wegovy led to up to 28% weight loss, mainly from fat, with muscle preserved, new trial data show.